This study documents the journey of one intractable Epilepsy patient contemplating the implantation of a Vagus Nerve Stimulation (VNS) device. Intractable, or pharmacoresistant, Epilepsy is Epilepsy that is uncontrolled despite appropriate medical treatment with antiepileptic drugs (AED's). More than 30% of patients continue to have seizures in spite of multiple trials with pharmacologic therapy (Kwan & Brodie 2000).
Scientists had long known that electrical stimulation of the vagus nerve in the neck could “flatten out” brain waves, thus possibly decreasing seizure activity, and in 1997, the U.S. Food and Drug Administration (FDA) approved VNS Therapy in combination with seizure medication. On the surface, it might appear that the decision would be an easy one, yet past frustrations and the uncertainty of favorable results make this decision one worth studying.
|School:||The University of Toledo|
|Department:||Arts and Sciences|
|School Location:||United States -- Ohio|
|Source:||MAI 57/06M(E), Masters Abstracts International|
|Keywords:||Intractable epilepsy, Seizures, Vagus nerve, Vns|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be